Increased leukotriene B(4) production, complement C3 conversion and acid hydrolase enzyme concentrations in different leucocyte sub-populations of dogs with atopic dermatitis.
Various markers of the inflammatory response were measured in peripheral blood mononuclear cells (PBMCs) and polymorphonuclear neutrophils (PMNs) from 31 dogs with atopic dermatitis (AD). The variables assayed included chemiluminescence, acid hydrolase enzyme concentrations, leukotriene B(4) (LTB(4)) production and complement C3 conversion. The results were compared to those derived from a population of clinically healthy dogs. Dogs with AD exhibited a significant increase in median LTB(4) production in PMNs compared to controls (0.94 versus 0.00 ng/10(6) cells; P<0.01). Significant increases in the median concentrations of intracellular beta-galactosidase (PBMC fraction - 0.42 versus 0.25 mU/10(6) cells; P<0.05) (PMN fraction - 0.47 versus 0.12 mU/10(6) cells; P<0.01) and beta-glucuronidase (PBMC fraction - 0.52 versus 0.27 mU/10(6) cells; P<0.05) were also evident in the AD group. Although median maximum chemiluminescence values for both leucocyte sub-populations were higher in controls, the differences recorded were not significant (P>0.05). However, the median time taken to reach maximum chemiluminescence was significantly shorter in the PMN fraction of dogs with AD (7.00 versus 10.00 min; P<0.01). Atopic dogs had a significant increase in the median percentage conversion of complement C3 to C3b (66.0 versus 57.3%; P<0.01). The results of this study indicate a priming of the inflammatory response in dogs with AD. The role of LTB(4) in the pathogenesis of canine AD and the potential efficacy of leukotriene antagonists in the treatment of this disorder warrant further investigation.
Breathnach
R
R
Department of Small Animal Clinical Studies, University College Dublin, Dublin 4, Ireland. rory.breathnach@ucd.ie
Donahy
C
C
Jones
B R
BR
Bloomfield
F J
FJ
D000818:Animals; D016022:Case-Control Studies; D003176:Complement C3 / Q000378:metabolism*; D003876:Dermatitis, Atopic / Q000097:blood / Q000201:enzymology / Q000276:immunology / Q000662:veterinary*; D004283:Dog Diseases / Q000097:blood / Q000201:enzymology* / Q000276:immunology; D004285:Dogs; D005260:Female; D006867:Hydrolases / Q000378:metabolism*; D007962:Leukocytes / Q000201:enzymology*; D007975:Leukotriene B4 / Q000096:biosynthesis*; D008163:Luminescent Measurements / Q000662:veterinary; D008297:Male; D009000:Monocytes / Q000201:enzymology; D009504:Neutrophils / Q000201:enzymology
D003176:Complement C3; D007975:Leukotriene B4; D006867:Hydrolases